HTG Molecular Diagnostics, Inc. Common Stock
HTGM
HTGM was delisted on the 14th of June, 2023.
21 hedge funds and large institutions have $28.4M invested in HTG Molecular Diagnostics, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 5 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
0% more funds holding
Funds holding: 21 → 21 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
31% less capital invested
Capital invested by funds: $41.2M → $28.4M (-$12.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$974K |
| 2 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$250K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$170K |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$89.6K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$49.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$1.39M |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$154K |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$29.3K |
| 4 |
Morgan Stanley
New York
|
-$21K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MTIP
26
Magee Thomson Investment Partners
San Diego,
California
| – | -$4K | -2 | Closed |
|
|
27
UBS Group
Zurich,
Switzerland
| – | -$5K | -2 | Closed |
|
HTGM Hedge Fund Activity: Q3 2015 in Review
21 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in HTG Molecular Diagnostics, Inc. Common Stock (HTGM) for Q3 2015, worth a combined $28.4M — down 31% from $41.2M a quarter earlier.
Fund positioning in HTGM was balanced in Q3 2015: 5 funds opened new positions, 5 closed out, 5 added to existing stakes and 1 trimmed.
The largest buyer was Putnam Investments, adding an estimated $974K. The largest seller was Emerald Mutual Fund Advisers Trust, exiting entirely with an estimated $1.39M sold.
- 21 institutional investors held HTG Molecular Diagnostics, Inc. Common Stock (HTGM) as of Q3 2015, unchanged from Q2 2015.
- Funds reported $28.4M of HTG Molecular Diagnostics, Inc. Common Stock stock for Q3 2015, down 31% quarter-over-quarter.
- 5 funds opened new HTG Molecular Diagnostics, Inc. Common Stock positions in Q3 2015 and 5 closed out, a net change of 0 holders.
- The largest HTG Molecular Diagnostics, Inc. Common Stock buyer in Q3 2015 was Putnam Investments, an estimated $974K added.
- The largest HTG Molecular Diagnostics, Inc. Common Stock seller in Q3 2015 was Emerald Mutual Fund Advisers Trust, an estimated $1.39M sold.
Based on aggregated 13F filings for Q3 2015.